Biograil
Health Care · Prescription Drugs
Overview
BIONDD®. BREAKTHROUGH TECHNOLOGY FOR ORAL DELIVERY OF BIOLOGICS.
Funding and backers
Total raised
$21.6M
1 round on record
Latest round
$21.6M
Venture round · Nov 2026 · this month
Backers
1
High-Tech Gründerfonds
The money's age
Fresh money
0 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 4
Raised a round Venture round $21.6M · EU-Startups
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Nov 2026 | $21.6M | Verve Ventures, Megatrend Invest | EU-Startups |
Registers and programsofficial lists and records that name the company
| Legal entity | Biograil ApS | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs Orbis Medicines
backs Laxxon Medical
Similar startupsby what they do, their industry and backers
Azurity Pharmaceuticals is a privately held specialty pharmaceutical company that develops and markets medicines for patients underserved…
Our team has extensive expertise in kidney disease, targeted delivery of RNA therapeutics, translational systems biology and data sciences…
We transform somatic genomics insights into potentially breakthrough medicines. Learn more at Quotient-Tx.com
Home. Exolvo Biosciences is an innovative biotech company leading the way in transforming the oral delivery of large, complex molecules.
The Company To date, there are no approved drugs for the treatment of sensorineural hearing loss disorder or tinnitus. AudioCure Pharma is…
3D screen printing pharmaceutical solutions company providing an advanced additive manufacturing platform engineered to produce…
Financials
Total raised
$21.6M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $21.6M | Details |
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
High-Tech GründerfondsVia a fund
516 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Copenhagen's Biograil raises €20 million for oral drug delivery device designed as an alternative to injections
Biograil, a Copenhagen-based BioTech company developing an oral device to deliver therapeutics that would otherwise require injection, has closed a €20 million funding round. The round was backed by Verve Ventures and Megatrend Invest. HTGF, which led the
Read more
Report